Anika Therapeutics, Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $13.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.4M | 10.3% |
| Other Financing | $1.2M | 8.5% |
| Working Capital | $3.5M | 25.5% |
| Other | $32.2K | 0.2% |
| Net Cash Flow | $7.6M | 55.5% |